GB1566609A
(en)
*
|
1977-03-10 |
1980-05-08 |
Reckitt & Colmann Prod Ltd |
Pharmaceutical compositions containing cholestyramine and alginic acid
|
GB1603640A
(en)
|
1977-07-20 |
1981-11-25 |
Gist Brocades Nv |
Enzyme particles
|
DE2923279B1
(de)
*
|
1979-06-08 |
1980-11-20 |
Kali Chemie Pharma Gmbh |
Verfahren zur Herstellung von Pankreatin-Pellets
|
FR2470599A1
(fr)
*
|
1979-12-07 |
1981-06-12 |
Panoz Donald |
Perfectionnements apportes aux procedes de preparation de formes galeniques a action retard et a liberation programmee et formes galeniques de medicaments ainsi obtenus
|
AU1234383A
(en)
*
|
1982-03-17 |
1983-09-22 |
Inter-Yeda Ltd. |
Interferon stabilised with polyvinyl-pyrrolidone
|
US4414198A
(en)
*
|
1982-04-23 |
1983-11-08 |
Joseph Michaelson |
Rapidly disintegrable tablet composition and method
|
US4477434A
(en)
*
|
1982-05-29 |
1984-10-16 |
Reiko Kosaka |
Medicinal compositions, foods and beverages having therapeutic effects on diseases of circulatory system and digestive system
|
DE3221425A1
(de)
*
|
1982-06-07 |
1983-12-08 |
Boehringer Ingelheim KG, 6507 Ingelheim |
Hydrolyseempfindlichen wirkstoff enthaltende, lagerstabile tablette
|
GB2130087A
(en)
*
|
1982-09-22 |
1984-05-31 |
Dr Joachime Helbig |
Pharmaceutical oral dosage forms of an active agent capable of forming or releasing bicarbonate ions
|
US4447412A
(en)
*
|
1983-02-01 |
1984-05-08 |
Bilton Gerald L |
Enzyme-containing digestive aid compostions
|
US5038396A
(en)
*
|
1983-10-03 |
1991-08-06 |
Mogens Gjerlov |
Preparation for rehydrating monogastric animals, including new-born calves, pigs and human beings suffering from diarrhoea and use thereof
|
DK454683D0
(da)
*
|
1983-10-03 |
1983-10-03 |
Mogens Gjerloev |
Tarmreguleringsmiddel til behandling af diarre hos dyr samt anvendelse heraf
|
EP0172166A1
(en)
*
|
1984-02-03 |
1986-02-26 |
Advanced Drug Technology Corporation |
Enzyme-containing digestive aid compositions
|
JPS61170390A
(ja)
*
|
1985-01-25 |
1986-08-01 |
Agency Of Ind Science & Technol |
酵素含有多糖複合体
|
US4863741A
(en)
*
|
1985-03-25 |
1989-09-05 |
Abbott Laboratories |
Tablet composition for drug combinations
|
US4874614A
(en)
*
|
1985-03-25 |
1989-10-17 |
Abbott Laboratories |
Pharmaceutical tableting method
|
US4844897A
(en)
*
|
1985-09-13 |
1989-07-04 |
Hiroshi Maeda |
Anti-tumor protease preparations
|
US4976949A
(en)
*
|
1985-10-25 |
1990-12-11 |
The University Of Michigan |
Controlled release dosage form
|
KR950014441B1
(ko)
*
|
1986-08-28 |
1995-11-28 |
코르텍스 리미티드 |
동물의 장에 생물학적 활성물질을 전달하는데 유용한 미세과립형 제제
|
WO1988001512A1
(en)
*
|
1986-08-28 |
1988-03-10 |
Thomas Ko Sai Ying |
Animal growth promotant
|
FR2618331B1
(fr)
*
|
1987-07-23 |
1991-10-04 |
Synthelabo |
Compositions pharmaceutiques utiles pour le traitement de l'uremie
|
US4851226A
(en)
*
|
1987-11-16 |
1989-07-25 |
Mcneil Consumer Products Company |
Chewable medicament tablet containing means for taste masking
|
US4944944A
(en)
*
|
1987-11-19 |
1990-07-31 |
Oklahoma Medical Research Foundation |
Dietary compositions and methods using bile salt-activated lipase
|
US5972685A
(en)
*
|
1988-07-21 |
1999-10-26 |
Iowa State University Research Foundation, Inc. |
Oral administration of coprostanol producing microorganisms to humans to decrease plasma cholesterol concentration
|
US5436004A
(en)
*
|
1988-07-21 |
1995-07-25 |
Iowa State University Research Foundation, Inc. |
Administration of cholesterol reductase to humans
|
DE3920561A1
(de)
*
|
1989-06-23 |
1991-01-10 |
Knoll Ag |
Verfahren zur vermeidung von verdauungsstoerungen bei pflanzenfressenden tieren
|
CA2030581C
(en)
*
|
1989-11-24 |
2000-06-27 |
Gunther Atzl |
Pancreatin preparations
|
EP0462723A1
(en)
*
|
1990-06-19 |
1991-12-27 |
BP Chemicals Limited |
Easily soluble granules containing a binding agent
|
US5281710A
(en)
*
|
1990-08-01 |
1994-01-25 |
The Scripps Research Institute |
Dynemicin analogs: synthesis, methods of preparation and use
|
US5229375A
(en)
*
|
1990-08-01 |
1993-07-20 |
Scripps Clinic And Research Foundation |
Phosphene oxide-terminated allene-ene-yne dna-cleaving, antitumor and antibiotic molecules
|
US5178864A
(en)
*
|
1990-08-14 |
1993-01-12 |
Mit |
Lipoprotein removal by soluble enzymes
|
EP0546075A4
(en)
*
|
1990-08-29 |
1993-07-28 |
Sterling Chaykin |
Method and product for eliminating undesirable side effects of eating vegetables such as onion or garlic
|
US6007809A
(en)
*
|
1990-08-29 |
1999-12-28 |
Chaykin; Sterling |
Method and product for eliminating undesirable side effects of eating vegetables such as onion or garlic
|
US5264586A
(en)
*
|
1991-07-17 |
1993-11-23 |
The Scripps Research Institute |
Analogs of calicheamicin gamma1I, method of making and using the same
|
US5902617A
(en)
*
|
1992-05-19 |
1999-05-11 |
Pabst; Patrea L. |
Enzyme supplemented baby formula
|
HRP930935A2
(en)
*
|
1992-06-11 |
1994-12-31 |
Astra Ab |
New dna sequences
|
US5262172A
(en)
*
|
1992-06-19 |
1993-11-16 |
Digestive Care Inc. |
Compositions of gastric acid-resistant microspheres containing buffered bile acids
|
US5302400A
(en)
*
|
1992-06-22 |
1994-04-12 |
Digestive Care Inc. |
Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids
|
US5460812A
(en)
*
|
1992-06-22 |
1995-10-24 |
Digestive Care Inc. |
Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
|
US5578304A
(en)
*
|
1992-06-22 |
1996-11-26 |
Digestive Care Inc. |
Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
|
US5234697A
(en)
*
|
1992-06-22 |
1993-08-10 |
Digestive Care Inc. |
Compositions of gastric acid-resistant microspheres containing salts of bile acids
|
US5260074A
(en)
*
|
1992-06-22 |
1993-11-09 |
Digestive Care Inc. |
Compositions of digestive enzymes and salts of bile acids and process for preparation thereof
|
US5415872A
(en)
*
|
1992-06-22 |
1995-05-16 |
Digestive Care Inc. |
Compositions of gastric acid-resistant microspheres containing salts of bile acids
|
DE4227385A1
(de)
*
|
1992-08-19 |
1994-02-24 |
Kali Chemie Pharma Gmbh |
Pankreatinmikropellets
|
US5352682A
(en)
*
|
1993-03-08 |
1994-10-04 |
Digestive Care Inc. |
Compositions containing salts of bile acid-aminosalicylate conjugates
|
US6428786B1
(en)
|
1993-09-28 |
2002-08-06 |
Mcneil-Ppc, Inc. |
Composition and method for lactose hydrolysis
|
US5445957A
(en)
*
|
1994-02-10 |
1995-08-29 |
Triarco Industries, Inc. |
Enzyme food supplement composition containing beta-fructofuranosidase, cellulase and hemicellulase
|
US5817641A
(en)
*
|
1994-07-21 |
1998-10-06 |
Thomas Jefferson University |
Treatment of enterotoxigenic diarrhea with 2-substituted adenosine derivatives
|
US5683720A
(en)
*
|
1994-10-28 |
1997-11-04 |
Fuisz Technologies Ltd. |
Liquiflash particles and method of making same
|
US6083430A
(en)
*
|
1994-10-28 |
2000-07-04 |
Fuisz Technologies Ltd. |
Method of preparing a dosage unit by direct tableting and product therefrom
|
US6083532A
(en)
*
|
1995-03-01 |
2000-07-04 |
Duramed Pharmaceuticals, Inc. |
Sustained release formulation containing three different types of polymers and tablet formed therefrom
|
US6057139A
(en)
*
|
1995-06-29 |
2000-05-02 |
Mcneil-Ppc, Inc. |
Preblend of microcrystalline cellulose and lactase for making tablets
|
US6365208B1
(en)
*
|
1995-06-29 |
2002-04-02 |
Mcneil-Ppc, Inc. |
Stable lactase tablets
|
US5618543A
(en)
*
|
1995-08-08 |
1997-04-08 |
Harris; Dennis H. |
Composition and method for reducing snoring and respiratory problems
|
WO1997012958A2
(en)
*
|
1995-10-06 |
1997-04-10 |
Genencor International, Inc. |
Microgranule for food/feed applications
|
US5807578A
(en)
*
|
1995-11-22 |
1998-09-15 |
Lab Pharmaceutical Research International Inc. |
Fast-melt tablet and method of making same
|
US5807577A
(en)
*
|
1995-11-22 |
1998-09-15 |
Lab Pharmaceutical Research International Inc. |
Fast-melt tablet and method of making same
|
KR100402037B1
(ko)
*
|
1995-12-05 |
2004-01-07 |
에스케이케미칼주식회사 |
베타-갈락토시다제의장용성약제
|
US5750104A
(en)
*
|
1996-05-29 |
1998-05-12 |
Digestive Care Inc. |
High buffer-containing enteric coating digestive enzyme bile acid compositions and method of treating digestive disorders therewith
|
AU717817B2
(en)
*
|
1996-06-06 |
2000-04-06 |
Bifodan A/S |
Enteric coating, comprising alginic acid, for an oral preparation
|
US5837292A
(en)
*
|
1996-07-03 |
1998-11-17 |
Yamanouchi Europe B.V. |
Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
|
US6140475A
(en)
*
|
1997-04-11 |
2000-10-31 |
Altus Biologics Inc. |
Controlled dissolution crosslinked protein crystals
|
UA65607C2
(uk)
*
|
1998-03-04 |
2004-04-15 |
Орто-Макнейл Фармацевтикал, Інк. |
Фармацевтична композиція (варіанти) та спосіб її приготування
|
FI980902A
(fi)
|
1998-04-23 |
1999-10-24 |
Orion Yhtymae Oyj |
Levosimendaanin stabiileja koostumuksia
|
US6346519B1
(en)
|
1998-09-09 |
2002-02-12 |
Advanced Medical Instruments |
Method and composition for treating arthritis
|
US6139875A
(en)
*
|
1998-09-29 |
2000-10-31 |
Eastman Chemical Company |
Aqueous enteric coating composition and low gastric permeability enteric coating
|
UA78486C2
(uk)
*
|
1999-12-10 |
2007-04-10 |
Хемджен Корпорейшн |
Композиція для перорального введення птахам та тваринам для лікування або зниження ризику інфекції травного тракту (варіанти), її застосування (варіанти) та спосіб лікування або зниження ризику інфекцій травного тракту (варіанти)
|
US6632429B1
(en)
*
|
1999-12-17 |
2003-10-14 |
Joan M. Fallon |
Methods for treating pervasive development disorders
|
US6534063B1
(en)
|
1999-12-17 |
2003-03-18 |
Joan M. Fallon |
Methods for treating pervasive development disorders
|
US20010046493A1
(en)
*
|
2000-02-24 |
2001-11-29 |
Alex Margolin |
Lipase-containing composition and methods of use thereof
|
US20070053895A1
(en)
*
|
2000-08-14 |
2007-03-08 |
Fallon Joan M |
Method of treating and diagnosing parkinsons disease and related dysautonomic disorders
|
KR20010007961A
(ko)
*
|
2000-10-30 |
2001-02-05 |
류형선 |
소화효소제의 장용성 제제 제조방법
|
IT1319655B1
(it)
|
2000-11-15 |
2003-10-23 |
Eurand Int |
Microsfere di enzimi pancreatici con elevata stabilita' e relativometodo di preparazione.
|
US8030002B2
(en)
|
2000-11-16 |
2011-10-04 |
Curemark Llc |
Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
|
BR0100334A
(pt)
*
|
2001-01-17 |
2002-09-24 |
Diffucap Chemobras Quimica E F |
Processo para a preparação de composições de liberação programada contendo venlafaxina e o produto resultante
|
WO2003068170A2
(en)
|
2002-02-14 |
2003-08-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Enzyme treatment of foodstuffs for celiac sprue
|
US20040197321A1
(en)
*
|
2002-03-19 |
2004-10-07 |
Tibor Sipos |
Composition and method to prevent or reduce diarrhea and steatorrhea in HIV patients
|
US20030180279A1
(en)
*
|
2002-03-19 |
2003-09-25 |
Tibor Sipos |
Composition and method to prevent or reduce diarrhea and steatorrhea in HIV patients
|
US20050266069A1
(en)
*
|
2002-09-06 |
2005-12-01 |
Simmons Donald L |
Stable probiotic microsphere compositions and their methods of preparation
|
US7067124B2
(en)
*
|
2003-03-28 |
2006-06-27 |
National Enzyme Company |
Protease composition and method for treating a digestive disorder
|
AU2005227090B2
(en)
|
2004-03-22 |
2010-12-09 |
Abbott Laboratories Gmbh |
Oral pharmaceutical compositions of lipase-containing products, in particular of pancreatin, containing surfactants
|
US20060029590A1
(en)
*
|
2004-06-10 |
2006-02-09 |
Christopher Thanos |
Administration of neutral endopeptidase to treat inflammatory bowel disease
|
EP2422804A1
(en)
*
|
2004-06-17 |
2012-02-29 |
Amano Enzyme USA., Ltd. |
Controlled release formulations of enzymes, microorganisms, and antibodies with mucoadhesive polymers
|
EP1781339B1
(en)
|
2004-06-25 |
2013-12-25 |
Thomas Jefferson University |
Guanylyl cyclase C ligands
|
US20060198838A1
(en)
*
|
2004-09-28 |
2006-09-07 |
Fallon Joan M |
Combination enzyme for cystic fibrosis
|
EP2198880B1
(en)
*
|
2004-10-14 |
2016-11-23 |
Eli Lilly And Co. |
Compositions containing lipase, protease and amylase for treating pancreatic insufficiency
|
KR100762304B1
(ko)
|
2005-07-22 |
2007-10-05 |
넨시스(주) |
구형 소화효소 과립제 및 이의 제조방법
|
AU2006274835B2
(en)
*
|
2005-07-29 |
2012-05-24 |
Abbott Laboratories Gmbh |
Processes for the manufacture of sterilized pancreatin powder
|
US11266607B2
(en)
*
|
2005-08-15 |
2022-03-08 |
AbbVie Pharmaceuticals GmbH |
Process for the manufacture and use of pancreatin micropellet cores
|
US9198871B2
(en)
|
2005-08-15 |
2015-12-01 |
Abbott Products Gmbh |
Delayed release pancreatin compositions
|
UA89102C2
(ru)
*
|
2005-08-15 |
2009-12-25 |
Солвей Фармасьютикалс Гмбх |
Ядра микропеллета панреатита, пригодные для нанесеня энтеросолюбильного покрытия
|
PL1931317T3
(pl)
*
|
2005-08-15 |
2009-06-30 |
Abbott Laboratories Gmbh |
Mikropeletki pankreatyny odpowiednie do powlekania powłoczką dojelitową
|
US20080058282A1
(en)
|
2005-08-30 |
2008-03-06 |
Fallon Joan M |
Use of lactulose in the treatment of autism
|
US20070116695A1
(en)
*
|
2005-09-21 |
2007-05-24 |
Fallon Joan M |
Pharmaceutical preparations for attention deficit disorder, attention deficit hyperactivity disorder and other associated disorders
|
US20100196344A1
(en)
*
|
2005-10-14 |
2010-08-05 |
Cystic Fibrosis Foundation Therapeutics, Inc. |
Compositions and methods for treating pancreatic insufficiency
|
US8071089B2
(en)
*
|
2005-11-01 |
2011-12-06 |
Bio-Cat, Inc. |
Composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrosis as well as people suffering from pancreatic lipase insufficiency
|
US10072256B2
(en)
|
2006-05-22 |
2018-09-11 |
Abbott Products Gmbh |
Process for separating and determining the viral load in a pancreatin sample
|
US20080199448A1
(en)
*
|
2007-02-16 |
2008-08-21 |
Ross Mairi R |
Enzyme composition for improving food digestion
|
US20090117180A1
(en)
*
|
2007-02-20 |
2009-05-07 |
Giovanni Ortenzi |
Stable digestive enzyme compositions
|
RU2445952C2
(ru)
*
|
2007-02-20 |
2012-03-27 |
Юранд Фармасьютикалз Лимитед |
Стабильные композиции пищеварительных ферментов
|
US8221747B2
(en)
*
|
2007-02-20 |
2012-07-17 |
Aptalis Pharma Limited |
Stable pancreatic enzyme compositions
|
EP2016838B1
(fr)
*
|
2007-06-18 |
2017-05-31 |
ET & DS Company Ltd |
Supplément alimentaire
|
US20090130063A1
(en)
*
|
2007-11-15 |
2009-05-21 |
Solvay Pharmaceuticals Gmbh |
Process for separating and determining the viral load in a pancreatin sample
|
US20110008423A1
(en)
*
|
2008-01-03 |
2011-01-13 |
Abbott Products Gmbh |
Pharmaceutical compositions comprising granules of purified microbial lipase and methods for preventing or treating digestive disorders
|
US10087493B2
(en)
|
2008-03-07 |
2018-10-02 |
Aptalis Pharma Canada Ulc |
Method for detecting infectious parvovirus in pharmaceutical preparations
|
US8658163B2
(en)
|
2008-03-13 |
2014-02-25 |
Curemark Llc |
Compositions and use thereof for treating symptoms of preeclampsia
|
US8084025B2
(en)
|
2008-04-18 |
2011-12-27 |
Curemark Llc |
Method for the treatment of the symptoms of drug and alcohol addiction
|
CA2726193C
(en)
|
2008-06-03 |
2018-11-27 |
University Of Rochester |
Methods of treating inflammatory intestinal disease and managing symptoms thereof
|
US9320780B2
(en)
|
2008-06-26 |
2016-04-26 |
Curemark Llc |
Methods and compositions for the treatment of symptoms of Williams Syndrome
|
ES2732453T3
(es)
|
2008-07-01 |
2019-11-22 |
Curemark Llc |
Métodos y composiciones para el tratamiento de síntomas de trastornos neurológicos y de salud mental
|
US20100021505A1
(en)
*
|
2008-07-28 |
2010-01-28 |
Tibor Sipos |
Composition and method to prevent or reduce diarrhea and steatorrhea in HIV patients
|
US10776453B2
(en)
*
|
2008-08-04 |
2020-09-15 |
Galenagen, Llc |
Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
|
WO2010025126A1
(en)
*
|
2008-08-26 |
2010-03-04 |
Cystic Fibrosis Foundation Therapeutics, Inc. |
Rapidly disintegrating tablets comprising lipase, amylase, and protease
|
US20100092447A1
(en)
|
2008-10-03 |
2010-04-15 |
Fallon Joan M |
Methods and compositions for the treatment of symptoms of prion diseases
|
WO2010080835A1
(en)
|
2009-01-06 |
2010-07-15 |
Curemark Llc |
Compositions and methods for the treatment or the prevention oral infections by e. coli
|
AU2015252099B2
(en)
*
|
2009-01-06 |
2017-08-10 |
Galenagen, Llc |
Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces
|
AU2010203709B2
(en)
|
2009-01-06 |
2014-05-22 |
Galenagen, Llc |
Compositions and methods for the treatment or prevention of Staphylococcus Aureus infections and for the Eradication or reduction of Staphylococcus Aureus on surfaces
|
US9056050B2
(en)
|
2009-04-13 |
2015-06-16 |
Curemark Llc |
Enzyme delivery systems and methods of preparation and use
|
US8784884B2
(en)
|
2009-09-17 |
2014-07-22 |
Stephen Perrett |
Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency
|
US9511125B2
(en)
|
2009-10-21 |
2016-12-06 |
Curemark Llc |
Methods and compositions for the treatment of influenza
|
US20110135728A1
(en)
*
|
2009-12-08 |
2011-06-09 |
Miller Jennifer L |
Gastric retentive pharmaceutical compositions for extended release of polypeptides
|
DE102010009582A1
(de)
|
2010-02-05 |
2011-08-11 |
Vitacare GmbH & Co. KG, 60318 |
Mittel zur Anwendung bei Lactasemangel und Lactoseintoleranz
|
EP2547331A4
(en)
*
|
2010-03-19 |
2014-04-30 |
Aptalis Pharma Canada Inc |
GASTRO-RESISTANT PHARMACEUTICAL COMPOSITIONS BASED ON ENZYMES
|
SI2621476T1
(sl)
|
2010-10-01 |
2014-12-31 |
Aptalis Pharma Limited |
Gastrorezistentne obloĹľene pankrelipazne formulacije z nizko trdnostjo
|
DK2701733T3
(da)
|
2011-04-21 |
2019-05-27 |
Curemark Llc |
Forbindelser til behandling af neuropsykiatriske forstyrrelser
|
ES2558756T3
(es)
|
2011-08-08 |
2016-02-08 |
Aptalis Pharma Limited |
Método para la prueba de disolución de composiciones sólidas que contienen enzimas digestivas
|
TWI434706B
(zh)
|
2011-12-15 |
2014-04-21 |
Ind Tech Res Inst |
腸溶及腸酵素可分解材料及其製備方法
|
MX363096B
(es)
*
|
2012-01-03 |
2019-03-08 |
Curemark Llc |
Composición farmacéutica para usarse en el tratamiento de la malnutrición en un sujeto que exhibe un trastorno de espectro de autismo (asd).
|
US10350278B2
(en)
|
2012-05-30 |
2019-07-16 |
Curemark, Llc |
Methods of treating Celiac disease
|
ES2784227T3
(es)
|
2013-08-09 |
2020-09-23 |
Allergan Pharmaceuticals Int Ltd |
Composición de enzimas digestivos adecuada para la administración entérica
|
CA2947998A1
(en)
|
2014-06-19 |
2015-12-23 |
Aptalis Pharma Ltd. |
Methods for removing viral contaminants from pancreatic extracts
|
US11918624B2
(en)
*
|
2020-06-10 |
2024-03-05 |
Kelsius Laboratories LLC |
Therapeutic composition for use in the treatment of COVID-19 and other cytokine storm associated disorders
|
US11541009B2
(en)
|
2020-09-10 |
2023-01-03 |
Curemark, Llc |
Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
|